Personalized Oncology Market to Reach USD 18.4 Billion by 2035 | AI, Genomics, Liquid Biopsy & Precision Medicine Driving Growth Across the U.S., Germany, UK, Japan & India


 

Market Overview

The Personalized Oncology Market is experiencing significant growth as precision medicine, genomic profiling, biomarker testing, and artificial intelligence (AI) reshape cancer diagnosis and treatment. Personalized oncology focuses on tailoring therapies based on a patient's genetic profile, tumor biomarkers, and molecular characteristics, enabling more effective treatments with improved clinical outcomes and reduced adverse effects. The increasing adoption of companion diagnostics, targeted therapies, immunotherapies, and next-generation sequencing (NGS) is accelerating the transition toward individualized cancer care.

According to MarketGenics, the global Personalized Oncology Market is projected to grow from USD 7.7 Billion in 2025 to USD 18.4 Billion by 2035, registering a CAGR of 9.1% during the forecast period. Rising investments in oncology research, precision medicine initiatives, AI-driven cancer diagnostics, and genomic sequencing technologies are expected to fuel sustained market growth through 2035.

To obtain a free sample research report - https://marketgenics.co/download-report-sample/personalized-oncology-market-93926?utm_source=Free&utm_medium=ruchika

Market Growth Drivers

  • Increasing prevalence of breast, lung, colorectal, prostate, and hematological cancers worldwide.
  • Growing adoption of precision oncology and personalized cancer therapies.
  • Rising demand for Next-Generation Sequencing (NGS) and comprehensive genomic profiling.
  • Expansion of AI-powered oncology diagnostics and biomarker discovery platforms.
  • Increasing use of companion diagnostics for targeted therapy selection.
  • Growth in immunotherapy, CAR-T cell therapy, and targeted biologic treatments.
  • Rising investments in cancer genomics, molecular diagnostics, and pharmaceutical R&D.
  • Government initiatives supporting precision medicine and cancer screening programs.
  • Growing collaboration between pharmaceutical companies, biotechnology firms, and research institutions.

Key Players

  • Roche Holding AG
  • AstraZeneca PLC
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Bristol Myers Squibb
  • Novartis AG
  • Johnson & Johnson
  • Eli Lilly and Company
  • Amgen Inc.
  • GSK plc
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Guardant Health, Inc.
  • Exact Sciences Corporation
  • Foundation Medicine
  • Tempus AI
  • SOPHiA GENETICS
  • Caris Life Sciences
  • NeoGenomics Laboratories

Regional Insights

North America

North America dominates the Personalized Oncology Market due to advanced healthcare infrastructure, widespread adoption of precision medicine, strong oncology research funding, and high utilization of genomic testing. The United States leads the market with significant investments in cancer therapeutics, AI-driven diagnostics, and clinical research.

Europe

Europe continues to witness robust market growth driven by expanding precision oncology programs, favorable reimbursement policies, increasing adoption of companion diagnostics, and strong investments in cancer research across Germany, the United Kingdom, France, Switzerland, and Italy.

Asia-Pacific

Asia-Pacific is projected to register the fastest CAGR during the forecast period. Countries including China, India, Japan, South Korea, Singapore, and Australia are investing heavily in genomic medicine, oncology research, precision diagnostics, and advanced cancer treatment infrastructure.

Latin America

Brazil and Mexico are emerging markets supported by improving access to molecular diagnostics, expanding oncology care, and increasing healthcare investments.

Middle East & Africa

The UAE and Saudi Arabia are strengthening cancer care through investments in precision medicine, genomic testing, and advanced oncology centers.

Future Outlook

The Personalized Oncology Market is expected to transform cancer care through continued advances in AI-powered diagnostics, genomic sequencing, liquid biopsy, multi-omics technologies, digital pathology, companion diagnostics, and targeted therapeutics. Innovations in gene editing, cell and gene therapies, predictive analytics, and precision immunotherapy will further improve treatment outcomes. As healthcare providers increasingly adopt personalized treatment strategies and pharmaceutical companies accelerate precision oncology drug development, the market is poised for sustained growth through 2035.

Related Reports:

Virtual Health Assistants Market

Smart Prosthetics Market

AI-powered EHR Systems Market

Digital Rehabilitation Market

Connected Ambulance Systems Market

Contact:
Mr. Debashish Roy
MarketGenics Global Research

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co

Comments

Post a Comment

Popular posts from this blog

Fertilizers Market Size, Growth, Trends & Forecast 2026–2035

Image
  Market Overview The global Fertilizers Market was valued at approximately USD 279.9 billion in 2025 and is projected to reach USD 430.5 billion by 2035 , registering a CAGR of 4.4% during 2026–2035 . The market is driven by increasing global food demand, declining arable land, soil nutrient depletion, and the need to improve crop productivity. Nitrogenous fertilizers represent the largest product segment, while demand for specialty fertilizers, micronutrients, controlled-release fertilizers, bio-fertilizers, and enhanced-efficiency fertilizers is increasing as farmers focus on nutrient-use efficiency and sustainable agricultural practices. To obtain a free sample research report - https://marketgenics.co/download-report-sample/fertilizers-market-69005 Market Growth Drivers Rising population and growing food consumption are major factors supporting the Fertilizers Market . Farmers are increasingly required to improve crop yields from limited agricultural land, increasi...
Read more

Asia-Pacific Immune-Boosting Functional Foods Market Analysis: Opportunities in China, India, Japan & South Korea

Image
  Market Overview The global immune-boosting functional foods market is valued at approximately USD 16 billion in 2025 and is projected to grow at a CAGR of around 7% from 2025 to 2035, reflecting increasing consumer interest in preventive healthcare, nutritional wellness, and foods that support normal immune function. Immune-boosting functional foods include nutrient-enriched products formulated with ingredients such as vitamins, minerals, probiotics, prebiotics, antioxidants, herbs, spices, fruits, vegetables, nuts, and seeds. Products such as fortified dairy foods, probiotic yogurt, fermented foods, functional snacks, and plant-based nutritional foods are gaining attention as consumers increasingly seek convenient ways to incorporate health-supporting nutrition into their daily diets. Manufacturers are focusing on clean-label formulations, natural ingredients, plant-based alternatives, and science-backed product development to respond to changing dietary preferences. Growing ...
Read more

Asia Pacific Brain-Computer Interfaces & Neuromodulators Market: Growth Opportunities Through 2035

Image
  Market Overview The global Brain-Computer Interfaces (BCI) and Neuromodulators Market is gaining momentum as advances in neuroscience, neural engineering, and digital healthcare create new opportunities for treating neurological disorders and improving human-computer interaction. The market combines brain-computer interface technologies, which translate brain activity into commands for external devices, with neuromodulation technologies that modify nerve activity through electrical or other forms of stimulation. These technologies support applications such as movement restoration, neurorehabilitation, communication assistance, chronic pain management, epilepsy treatment, and deep brain stimulation for selected neurological conditions. Growing collaboration among medical device manufacturers, biotechnology companies, research institutions, and technology developers is accelerating innovation in neural implants, wearable sensors, brain-signal processing, and personalized neuromo...
Read more